Intuitive Surgical (NASDAQ:ISRG) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Intuitive Surgical (NASDAQ:ISRG) posted its quarterly earnings results on Thursday. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10, Briefing.com reports. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 13.27%. Intuitive Surgical’s revenue was up 11.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 earnings per share.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $366.34 on Friday. The firm has a market cap of $129.85 billion, a P/E ratio of 66.13, a P/E/G ratio of 5.78 and a beta of 1.36. Intuitive Surgical has a 1-year low of $254.85 and a 1-year high of $403.76. The firm has a fifty day moving average of $386.84 and a two-hundred day moving average of $343.10.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 24,325 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the sale, the chief executive officer now owns 9,425 shares in the company, valued at $3,544,365.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Intuitive Surgical news, CEO Gary S. Guthart sold 24,325 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $376.06, for a total value of $9,147,659.50. Following the transaction, the chief executive officer now owns 9,425 shares in the company, valued at approximately $3,544,365.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock valued at $95,927,097 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Large investors have recently modified their holdings of the company. O Dell Group LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $30,000. PCA Investment Advisory Services Inc. bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $35,000. Strategic Investment Solutions Inc. IL bought a new stake in shares of Intuitive Surgical during the 1st quarter worth $39,000. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Intuitive Surgical by 176.2% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 116 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 74 shares during the period. Finally, Cornerstone Planning Group LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $51,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

ISRG has been the topic of a number of recent analyst reports. Citigroup increased their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. BTIG Research raised their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday. Finally, Piper Sandler raised their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.